Items where Author is "Sorenson, Corinna"

Number of items: 48.
  • Improving medical device regulation: the United States and Europe in perspective. (2014) Sorenson, Corinna; Drummond, Michael
  • The politics of comparative effectiveness research: lessons from recent history. (2014) Sorenson, Corinna; Gusmano, M.; Oliver, Adam
  • Use of innovation payments to encourage the adoption of new medical technologies in the English NHS. (2013) Sorenson, Corinna; Drummond, Michael; Wilkinson, Grahame
  • Medical technology as a key driver of rising health expenditures: disentangling the relationship. (2013) Sorenson, Corinna; Drummond, Michael; Bhuiyan Kahn, Beena
  • Evolving reimbursement and pricing policies for devices in Europe and the United States should encourage greater value. (2013) Sorenson, Corinna; Drummond, Michael; Burns, Lawton R.
  • Comparative effectiveness research: the experience of the National Institute for Health and Clinical Excellence. (2012) Sorenson, Corinna; Drummond, Mike; Chalkidou, Kalipso
  • Valuing end-of-life care in the United States: the case of new cancer drugs. (2012) Sorenson, Corinna
  • The socioeconomic value of orthopaedic devices: evidence and methodological and challenges. (2012) Sorenson, Corinna; Drummond, Mike
  • Measuring value: pharmacoeconomics theory and practice. (2012) Towse, A; Drummond, Michael; Sorenson, Corinna
  • Reflections on the evolution of health technology assessment in Europe. (2012) Sorenson, Corinna; Chalkidou, K.
  • Evidence of comparative efficacy should have a formal role in European drug approvals. (2011) Sorenson, Corinna; Naci, Huseyin; Cylus, Jonathan; Mossialos, Elias
  • Measuring value: pharmacoeconomics in theory and practice. (2011) Towse, Adrian; Drummond, Michael; Sorenson, Corinna
  • Applying health economics for policy decision making: how much do devices differ from drugs? (2011) Sorenson, Corinna; Tarricone, Rosanna; Siebert, Markus; Drummond, Michael
  • Medical technology procurement in Europe: a cross-country comparison of current practice and policy. (2011) Sorenson, Corinna; Kanavos, Panos
  • Infectious disease surveillance in the United States and the United Kingdom: from public goods to the challenges of new technologies. (2011) Barnett, Tony; Sorenson, Corinna
  • Public financing of IVF: a review of policy rationales. (2010) Mladovsky, Philipa; Sorenson, Corinna
  • Use of pharmacoeconomics in drug reimbursement in Australia, Canada and the UK: what can we learn from international experience? (2009) Drummond, Michael; Sorenson, Corinna
  • Nasty or nice?: a perspective on the use of health technology assessment in the United Kingdom. (2009) Drummond, Michael; Sorenson, Corinna
  • The limitations and challenges to the economic evaluation of health technologies. (2009) Sorenson, Corinna; Oliver, Adam
  • The limits and challenges to the economic evaluation of health technologies. (2009) Oliver, Adam; Sorenson, Corinna
  • Can NICE be nicer?: in a world of budget constraints there are no easy solutions. (2009) Drummond, Michael; Sorenson, Corinna
  • HTA in Central and Eastern Europe: current status, challenges and opportunities. (2009) Sorenson, Corinna; Kanavos, Panos; Karamalis, M.
  • Product development partnerships (PDPs) for neglected diseases: considerations on governance. (2009) Sorenson, Corinna
  • Topic 1: financing medical devices in France and the UK. (2009) Sorenson, Corinna; Kanavos, Panos
  • The role of HTA in coverage and pricing decisions: a cross-country comparison. (2009) Sorenson, Corinna
  • Does the work of the National Institute for Health and Clinical Excellence (NICE) have any relevance for the United States? (2008) Sorenson, Corinna; Drummond, Michael; Kanavos, Panos; McGuire, Alistair
  • Financing of medical technologies in Europe: the case of the UK and France. (2008) Sorenson, Corinna
  • Importance of preference reversals in the valuation of health and healthcare. (2008) Oliver, Adam; Sorenson, Corinna
  • National Institute for Health and Clinical Excellence (NICE). How does it work and what are the implications for the U.S? (2008) Sorenson, Corinna; Drummond, Michael; Kanavos, Panos; McGuire, Alistair
  • How can the impact of health technology assessments be enhanced? (2008) Sorenson, Corinna; Drummond, Michael; Kristensen, Finn Børlum; Busse, Reinhard
  • On equity in the English National Health Service. (2008) Oliver, Adam; Sorenson, Corinna
  • The procurement landscape for medical devices in England: recent developments and applications to wound care. (2008) Sorenson, Corinna
  • Balancing intellectual monopoly privileges and the need for essential medicines. (2007) Martin, Greg; Sorenson, Corinna; Faunce, Thomas
  • Measuring quality and standards of long-term care for older people. (2007) Sorenson, Corinna; Mossialos, Elias
  • Measuring inequalities in access to health care: a review of the indices? (2007) Allin, Sara; Masseria, Cristina; Sorenson, Corinna; Papanicolas, Irene; Mossialos, Elias
  • Quality measurement and assurance of long-term care for older people. (2007) Sorenson, Corinna
  • What are the methodological issues related to measuring health and drawing comparisons across countries? (2007) Masseria, Cristina; Allin, Sara; Sorenson, Corinna; Papanicolas, Irene; Mossialos, Elias
  • Assisted reproduction technologies in Europe: an overview. (2006) Sorenson, Corinna; Mladovsky, Philipa
  • ART in the European Union. (2006) Sorenson, Corinna
  • ART treatment in the EU: NICE guidelines for infertility treatment. (2006) Sorenson, Corinna; Mladovsky, Philipa
  • Children's lifestyles in Europe. (2006) Sorenson, Corinna
  • IVF/ART funding and reimbursement. (2006) Sorenson, Corinna
  • NICE guidelines for fertility treatment. (2006) Sorenson, Corinna; Mladovsky, Philipa
  • TRIPS, trade, and tablets for all: balancing intellectual property and the demand for medicine. (2006) Martin, Greg; Sorenson, Corinna
  • Development of a health economic model to demonstrate the costs and morbidity implications of an investigational obesity drug: technical report prepared for a US pharmaceutical company. (2004) Sorenson, Corinna; Gemmen, Eric
  • An innovative approach to post-market surveillance of emerging adverse events. (2004) Sorenson, Corinna; Robboy, E.
  • Ensuring value for money in health care: The role of HTA in the European Union. Sorenson, Corinna; Drummond, Michael; Kanavos, Panos
  • Use of comparative effectiveness research in drug coverage and pricing decisions: a six-country comparison. Sorenson, Corinna